RSS   Newsletter   Contact   Advertise with us
Post Online Media

Veristat appoints James Roach as chief medical officer

VeristatVeristat, a clinical research organization, announced that it has appointed James Roach as its new chief medical officer, effective December 2, 2016.

Dr. Roach joins Veristat with over 20 years of experience supporting clinical development, registration, commercialization and product lifecycle strategy at several biotechnology, pharmaceutical and clinical research firms.

He brings a diverse background of therapeutic experience that strategically aligns with Veristat’s core therapeutic areas of Oncology, Rare Diseases, CNS disorders and Cardiovascular disease.

Additionally, his expertise with Autoimmune/Inflammation will be instrumental to expanding that knowledge base.

Throughout his career, he has built and led clinical research, clinical development operations, medical affairs, and regulatory affairs teams, working in unison to bring numerous products through the regulatory submission process.

Most recently, Dr. Roach served as Senior Vice President of Development and Chief Medical Officer at Momenta Pharmaceuticals and prior was the Senior Vice President of Medical Affairs at Sepracor Inc.

He has also held leadership roles in Clinical Research and Medical Affairs at Millennium Pharmaceuticals, LeukoSite, Inc (acquired by Millennium) and Astra USA, and also led the Medical Affairs, Safety/Pharmacovigilance and Medical Monitoring functions at Medical and Technical Research Associates (MTRA), a contract research organization acquired by AAI Pharma.

Dr. Roach has also maintained an academic appointment at Harvard Medical School and has been an Associate Physician at Brigham and Women’s Hospital (BWH) and member of the BWH Pulmonary and Critical Care Medicine Division since 1993.


 LATEST MOVES FROM Massachusetts 





More inside POST
 
 

We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy